Abstract
Retinoids have demonstrated antiinflammatory activity in certain animal models and human disease states. The mechanism by which retinoids elicit this activity is unknown. Some retinoids are known to inhibit arachidonic acid (AA) release and metabolism in intact cells in vitro. Retinoids may exert their antiinflammatory effects by inhibiting phospholipase A2 (PLA2) and the resultant production of inflammatory AA metabolites. Retinoids were evaluated in vitro as inhibitors of the PLA2 activity in human synovial fluid (HSF-PLA2). Of the naturally occurring, nonaromatic retinoids tested, all-trans-retinal, all-trans-retinoic acid (all-trans-RA) and 13-cis-RA were the most potent inhibitors (IC50 s 6–15ΜM), whereas all-trans-retinol was much less potent. Of the synthetic aromatic retinoids and arotinoids examined, the free carboxylic, sulfonic, and sulfinic acid forms were more than 15-fold more potent inhibitors of HSF-PLA2 than their corresponding ethyl esters. These retinoids also were evaluated as inhibitors of calcium ionophore A23187-induced AA release from rat peritoneal macrophages. All-trans-RA and 13-cis-RA were potent inhibitors of AA release from these cells (IC50 s 4ΜM), while the other natural retinoids were inactive. Of the aromatic retinoids and arotinoids tested, the free acid forms (IC50 s 2–6ΜM) were 5- to 21-fold more potent inhibitors of AA release from the macrophages than their corresponding ethyl esters. The potencies of the arotinoids as inhibitors of HSF-PLA2 appeared to correlate with their potencies as inhibitors of AA release from A23187-stimulated rat peritoneal macrophages. These data support the hypothesis that one possible mechanism for the known antiinflammatory activity of some retinoids may be by inhibition of phospholipase A2.
Similar content being viewed by others
References
Brinckerhoff, C. E., J. W. Coffey, andA. C. Sullivan. 1983. Inflammation and collagenase production in rats with adjuvant arthritis reduced with 13-cis-retinoic acid.Science 221:756–758.
Haraoui, B., R. L. Wilder, J. B. Allen, M. B. Sporn, R. K. Helfgott, andC. E. Brinck-Erhoff. 1985. Dose-dependent suppression by the synthetic retinoid, 4-hydroxyphenyl retinamide of streptococcal cell wall-induced arthritis in rats.Int. J. Immunopharmacol. 7:903–916.
Orfanos, C. E., andR. Bauer. 1983. Evidence for antiinflammatory activity of oral and synthetic retinoids: Experimental findings and clinical experience.Br. J. Dermatol. 109 (Suppl. 25):55–60.
Smith, E. L., andJ. J. Tegeler. 1989. Advances in dermatology.Annu. Rep. Med. Chem. 24:177–196.
Nigam S., S.Müller, and R.Stadler. 1988. Arotinoids as inhibitors of arachidonic acid (AA) release and metabolism in human blood cells. Taipei Conference on Prostaglandin and Leukotriene Research. Abstract S115.
Vane, J. R. 1972. Prostaglandins in the inflammatory response.In Inflammation: Mechanisms and Control. I. H. Lepow and P. A. Ward, editors. Academic Press, New York, 261–279.
Pruzanski, W., E. C. Keystone, C. Bombardier, K. M. Snow, andP. Vadas. 1987. Phospholipase A2 correlates with disease activity in rheumatoid arthritis.Arthritis Rheum. 30:S114 (Abstract E11).
Roenigh, H. H. 1987. Retinoids: Experimental and clinical results, general introduction.Dermatologica 175(Suppl. 1):5–7.
Fawzy, A. A., andR. C. Franson. 1986. Purification and characterization of human synovial fluid phospholipase A2.Biophys. J. 49:533a.
Hope, W. C., B. J.Patel, and G. A.Wiggan. 1988. Retinoids as inhibitors of human synovial fluid phospholipase A2. Inflammation Research Association Meeting, Therapeutic Control of Inflammatory Diseases, White Haven, Pennsylvania. October 23–27, Abstract 133.
Fiedler-Nagy, C., B. H. Wittreich, A. Georgiadis, W. C. Hope, A. F. Welton, andJ. W. Coffey. 1987. Comparative study of natural and synthetic retinoids as inhibitors of arachidonic acid release and metabolism in rat peritoneal macrophages.Dermatologica 175(Suppl. 1):81–92.
Fawzy, A. A., B. S. Vishwanath, andR. C. Franson. 1988. Inhibition of human nonpancreatic phospholipases A2 by retinoids and flavonoids. Mechanism of action.Agents Actions 25:394–400.
Wallach, D. P., andV. J. R. Brown. 1981. Studies on the arachidonic acid cascade-I. Inhibition of phospholipase A2 in vitro and in vivo by several novel series of inhibitor compounds.Biochem. Pharmacol. 30:1315–1324.
Vargaftig, B. B., andN. Dao Hai. 1972. Selective inhibition by mepacrine of the release of “rabbit aorta contracting substanceℍ evoked by the administration of bradykinin.J. Pharm. Pharmacol. 62:79–89.
Volwerk, J. J., W. A. Pieterson, andG. H. Dehaas. 1974. Histidine at the active site of phospholipase A2.Biochemistry 13:1446–1454.
Lombardo, D., andE. A. Dennis. 1985. Cobra venom phospholipase A2 inhibition by manoalide. A novel type of phospholipase A2 inhibitor.J. Biol. Chem. 260:7234–7240.
Fiedler-Nagy, C., A. Georgiadis, andJ. W. Coffey. 1985. Effects of retinoids on arachidonic acid release and metabolism by rat peritoneal macrophages.Agents Actions 16:620–621.
Hope, W. C., B. J.Patel, C.Fiedler-Nagy, B. H.Wittreich, and A. F.Welton. 1989. Comparison of retinoids as inhibitors of phospholipase A2 in human synovial fluid and of arachidonic acid release from rat peritoneal macrophages. Presented at the 1989 Winter Prostaglandin Conference, Keystone, Colorado, January.
Bray, M. A. 1984. Retinoids are potent inhibitors of the generation of rat leukocyte leukotriene B4-like activity in vivo.Eur. J. Pharmacol. 98:61–67.
Nigam, S. 1987. Inhibition of lipoxygenase products by retinoids in human blood cells.Dermatologica 175(Suppl. 1):73–80.
Franson, R., R. Dobrow, J. Weiss, P. Elsbach, andW. B. Weglicki. 1978. Isolation and characterization of a phospholipase A2 from an inflammatory exudate.J. Lipid Res. 19:18–23.
Bligh, E. G., andW. J. Dyer. 1959. A rapid method of total lipid extraction and purification.Can. J. Biochem. Physiol. 37:911–917.
Vadas, P., E. Stefanski, andW. Pruzanski. 1986. Influence of plasma proteins on activity of proinflammatory enzyme phospholipase A2.Inflammation 10:183–193.
Fawzy, A. A., R. Dobrow, andR. C. Franson. 1987. Modulation of phospholipase A2 activity in human synovial fluid by cations.Inflammation 11:389–400.
Jacobson, P., L. Marshall, M. Amy Sung, andR. Jacobs. 1989. Inactivation of human synovial fluid phospholipase A2 by manoalide.FASEB J. 3:A595.
Mobilio, D., andL. A. Marshall. 1989. Recent advances in the design and evaluation of inhibitors of phospholipase A2.Annu. Rep. Med. Chem. 24:157–166.
Geiger, J.-M., andC. J. Brindley. 1988.cis-trans Interconversion of acitretin in man.Skin Pharmacol 1:230–236.
Nakano, T., K. Hanasaki, S. Matsumoto, andH. Arita. 1988. Retinol induces platelet aggregation via activation of phospholipase A2.Biochem. Biophys. Res. Commun. 154:1075–1080.
Stillwell, W., M. Ricketts, H. Hudson, andS. Nahmias. 1982. Effect of retinol and retinoic acid on permeability, electrical resistance and phase transition of lipid bilayers.Biochem. Biophys. Acta 688:653–659.
Langsford, C. A., M. R. Albrecht, T. M. Phelps, W. Stillwell, andS. R. Wassall. 1987.Biophys. J. 51:239a.
Smythies, J. 1980. Prostaglandins and cancer: Further stereochemical studies on the molecule of phospholipase A2.Psychoneuroendocrinology 5:353–358.
Cantelmi, A., A. Gaiti, G. Porcellati, V. Ansidei, andM. Binazzi. 1982. Modulation of phospholipase A activity in psoriatic skin.Farmaco Ed. Sci. 37:612–617.
Marcelo, C., L. Rhodes, andS. Bulengo. 1988. Epidermal keratinocyte phospholipase A2 and C: Characterization and effect of steroids and retinoids.Clin. Res. 36:671A.
Marcelo, C., R. Bartel, andJ. Fortune. 1986. Effect of retinoids and glucocorticoids on phospholipase A2 and C mediated release of arachidonic acid by murine keratinocyte cultures.Clin. Res. 34:766A.
Punnonen, K., T. Puustinen, andC. Jansén. 1986. The effect of the antipsoriatic drug metabolite etretin (Ro 10-1670) on UVB irradiation induced changes in the metabolism of arachidonic acid in human keratinocytes in culture.Photochem. Photobiol. 44:623–267.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hope, W.C., Patel, B.J., Fiedler-Nagy, C. et al. Retinoids inhibit phospholipase A2 in human synovial fluid and arachidonic acid release from rat peritoneal macrophages. Inflammation 14, 543–559 (1990). https://doi.org/10.1007/BF00914275
Issue Date:
DOI: https://doi.org/10.1007/BF00914275